Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD

In this podcast recorded in early March, David Phizackerley (DTB Editor-in-Chief) and James Cave (DTB Editor-in-Chief Emeritus) provide an overview of the April 2025 issue of DTB. The editorial discusses concerns over the use of feminist empowerment messages to sell tests and treatments - . A DTB Select item summarises the results of an observational study that assessed the association between initiation of a triptan and the risk of myocardial infarction or stroke - . The main article provides an overview of initiating angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists in adults with CKD, highlighting current guideline recommendations and providing a practical approach to dealing with the challenges associated with their use - . Links Health Innovation Network: Tackling overprescribing report: GP Evidence: ( ) Please

You can listen to Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD online on Radio and Podcast. Open the player on this page to stream the available audio.

Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD is an episode from DTB podcast by BMJ Group.

This episode is 28:17 long.

This episode was published on Apr 2, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DTB podcast when more episodes are available from the podcast feed.